{"id":"https://openalex.org/W2997602829","doi":"https://doi.org/10.1016/j.jaci.2019.10.041","title":"Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis","display_name":"Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis","publication_year":2019,"publication_date":"2019-12-26","ids":{"openalex":"https://openalex.org/W2997602829","doi":"https://doi.org/10.1016/j.jaci.2019.10.041","mag":"2997602829","pmid":"https://pubmed.ncbi.nlm.nih.gov/31883845"},"language":"en","primary_location":{"id":"doi:10.1016/j.jaci.2019.10.041","doi":"https://doi.org/10.1016/j.jaci.2019.10.041","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jaci.2019.10.041","pdf_url":null,"source":{"id":"https://openalex.org/S108525051","display_name":"Journal of Allergy and Clinical Immunology","issn_l":"0091-6749","issn":["0091-6749","1085-8725","1097-6825"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Allergy and Clinical Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012513688","display_name":"Lewis E. Tomalin","orcid":"https://orcid.org/0000-0003-4545-7138","observed_orcids":["https://orcid.org/0000-0003-4545-7138"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lewis E. Tomalin","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":"https://orcid.org/0000-0003-4545-7138","affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070208317","display_name":"Chris B. Russell","orcid":"https://orcid.org/0000-0002-0240-1815","observed_orcids":["https://orcid.org/0000-0002-0240-1815"]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris B. Russell","raw_affiliation_strings":["BioMarin Pharmaceutical Inc, Novato, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMarin Pharmaceutical Inc, Novato, Calif","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067348327","display_name":"Sandra Garcet","orcid":"https://orcid.org/0000-0002-4465-8547","observed_orcids":["https://orcid.org/0000-0002-4465-8547"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Garcet","raw_affiliation_strings":["The Rockefeller University, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Rockefeller University, New York, NY","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065178554","display_name":"David Adrian Ewald","orcid":"https://orcid.org/0000-0001-6620-2738","observed_orcids":["https://orcid.org/0000-0001-6620-2738"]},"institutions":[{"id":"https://openalex.org/I4210165112","display_name":"Leo Pharma (Denmark)","ror":"https://ror.org/05tzrdd39","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210124980","https://openalex.org/I4210165112"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"David Adrian Ewald","raw_affiliation_strings":["Leo Pharma A/S, Ballerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leo Pharma A/S, Ballerup, Denmark","institution_ids":["https://openalex.org/I4210165112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032504505","display_name":"Paul A. Klekotka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Klekotka","raw_affiliation_strings":["Lilly Biotechnology Center, San Diego, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Biotechnology Center, San Diego, Calif","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039577185","display_name":"Ajay Nirula","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ajay Nirula","raw_affiliation_strings":["Lilly Biotechnology Center, San Diego, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Biotechnology Center, San Diego, Calif","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039388609","display_name":"Hanne Norsgaard","orcid":"https://orcid.org/0000-0002-5249-6701","observed_orcids":["https://orcid.org/0000-0002-5249-6701"]},"institutions":[{"id":"https://openalex.org/I4210165112","display_name":"Leo Pharma (Denmark)","ror":"https://ror.org/05tzrdd39","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210124980","https://openalex.org/I4210165112"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hanne Norsgaard","raw_affiliation_strings":["Leo Pharma A/S, Ballerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leo Pharma A/S, Ballerup, Denmark","institution_ids":["https://openalex.org/I4210165112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074081568","display_name":"Mayte Su\u00e1rez\u2010Fari\u00f1as","orcid":"https://orcid.org/0000-0001-8712-3553","observed_orcids":["https://orcid.org/0000-0001-8712-3553"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mayte Su\u00e0rez-Fari\u00f1as","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Mayte.SuarezFarinas@mssm.edu","Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Mayte.SuarezFarinas@mssm.edu","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080337749","display_name":"James G. Krueger","orcid":"https://orcid.org/0000-0002-3775-1778","observed_orcids":["https://orcid.org/0000-0002-3775-1778"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James G. Krueger","raw_affiliation_strings":["The Rockefeller University, New York, NY. Electronic address: kruegej@mail.rockefeller.edu","The Rockefeller University, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Rockefeller University, New York, NY. Electronic address: kruegej@mail.rockefeller.edu","institution_ids":["https://openalex.org/I83399316"]},{"raw_affiliation_string":"The Rockefeller University, New York, NY","institution_ids":["https://openalex.org/I83399316"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5074081568","https://openalex.org/A5080337749"],"corresponding_institution_ids":["https://openalex.org/I83399316","https://openalex.org/I98704320"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":2.4926,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.89984027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"145","issue":"3","first_page":"922","last_page":"932"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.953000009059906},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":1.0},{"id":"https://openalex.org/keywords/il-17a","display_name":"IL-17A","score":0.6899999976158142},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.6330000162124634},{"id":"https://openalex.org/keywords/lesional-skin","display_name":"lesional skin","score":0.7459999918937683},{"id":"https://openalex.org/keywords/il-23","display_name":"IL-23","score":0.6499999761581421},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.8859999775886536},{"id":"https://openalex.org/keywords/il-17c","display_name":"IL-17C","score":0.6539999842643738},{"id":"https://openalex.org/keywords/il-17f","display_name":"IL-17F","score":0.7829999923706055},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.6079999804496765},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.9739999771118164},{"id":"https://openalex.org/keywords/epidermal-thickness","display_name":"epidermal thickness","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8579257726669312},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7359864711761475},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.6480323076248169},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.5472993850708008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46235498785972595},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38318565487861633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3331179618835449},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.21374687552452087},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D053722","descriptor_name":"Receptors, Interleukin-17","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D059467","descriptor_name":"Transcriptome","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jaci.2019.10.041","doi":"https://doi.org/10.1016/j.jaci.2019.10.041","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jaci.2019.10.041","pdf_url":null,"source":{"id":"https://openalex.org/S108525051","display_name":"Journal of Allergy and Clinical Immunology","issn_l":"0091-6749","issn":["0091-6749","1085-8725","1097-6825"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Allergy and Clinical Immunology","raw_type":"journal-article"},{"id":"pmid:31883845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31883845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of allergy and clinical immunology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309418","display_name":"Irma T. Hirschl Trust","ror":"https://ror.org/01yaqvf46"},{"id":"https://openalex.org/F4320313189","display_name":"Rockefeller University","ror":"https://ror.org/0420db125"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1587070562","https://openalex.org/W1928646564","https://openalex.org/W1973354423","https://openalex.org/W1973614663","https://openalex.org/W1979058179","https://openalex.org/W1982598880","https://openalex.org/W1987430117","https://openalex.org/W2019678439","https://openalex.org/W2020760332","https://openalex.org/W2042118950","https://openalex.org/W2068218694","https://openalex.org/W2073441708","https://openalex.org/W2080090843","https://openalex.org/W2081098333","https://openalex.org/W2086210534","https://openalex.org/W2103018315","https://openalex.org/W2107665951","https://openalex.org/W2112276896","https://openalex.org/W2116956799","https://openalex.org/W2121900420","https://openalex.org/W2145834141","https://openalex.org/W2149566497","https://openalex.org/W2151991135","https://openalex.org/W2171889601","https://openalex.org/W2237859981","https://openalex.org/W2276035339","https://openalex.org/W2312279372","https://openalex.org/W2313512314","https://openalex.org/W2326643498","https://openalex.org/W2464558465","https://openalex.org/W2523439769","https://openalex.org/W2524969278","https://openalex.org/W2558568353","https://openalex.org/W2913107894","https://openalex.org/W2946192037","https://openalex.org/W4248269869","https://openalex.org/W6645172339"],"related_works":["https://openalex.org/W2145834141","https://openalex.org/W2078674248","https://openalex.org/W4414573757","https://openalex.org/W3011433060","https://openalex.org/W3015565870","https://openalex.org/W1982598880","https://openalex.org/W2801383894","https://openalex.org/W2701201582","https://openalex.org/W2296439405","https://openalex.org/W4386723850"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-01-10T00:00:00"}